2018
Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
HOŘÁK, Martin, Daniela KURUCZOVÁ, Filip ZLÁMAL, Josef TOMANDL, Julie DOBROVOLNÁ et. al.Základní údaje
Originální název
Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
Autoři
HOŘÁK, Martin (203 Česká republika, garant, domácí), Daniela KURUCZOVÁ (703 Slovensko, domácí), Filip ZLÁMAL (203 Česká republika, domácí), Josef TOMANDL (203 Česká republika, domácí) a Julie DOBROVOLNÁ (203 Česká republika)
Vydání
Disease Markers, London, Hindawi Publishing Corporation, 2018, 0278-0240
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.761
Kód RIV
RIV/00216224:14110/18:00106292
Organizační jednotka
Lékařská fakulta
UT WoS
000451854900001
Klíčová slova anglicky
Follistatin-like 1
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 26. 3. 2019 10:31, Soňa Böhmová
Anotace
V originále
Follistatin-like 1 (FSTL1) is a secreted adipomyokine with a possible link to obesity; however, its connection to extreme obesity currently remains unknown. In order to analyze such association for the very first time, we employed a unique cohort of morbidly and super obese individuals with a mean BMI of 44.77 kg/m(2) and measured the levels of circulating FSTL1. We explored the 3' UTR of FSTL1 to locate a genetic variant which impairs microRNA binding. We located and investigated such SNP (rs1057231) in relation to the FSTL1 protein level, obesity status, and other body composition parameters. We observed a significant decline in FSTL1 level in obese subjects in comparison to nonobese ones. The evaluated SNP was found to correlate with FSTL1 only in nonobese subjects. The presented results were not affected by sex since both males and females expressed FSTL1 equally. We suggest that the FSTL1 decrease observed in extremely obese subjects is a result of adipogenesis reduction accompanied by a senescence of preadipocytes which otherwise willingly express FSTL1, increased adipocyte apoptosis, and epigenetic FSTL1 silencing.
Návaznosti
EF15_003/0000469, projekt VaV |
| ||
LM2015051, projekt VaV |
|